Evidence map›Paper›PMID 33414813›Full record

ArticleFrontiers in genetics2020

Identification of Hub Genes Associated With Development and Microenvironment of Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis and Differential Gene Expression Analysis.

Qingquan Bai, Haoling Liu, Hongyu Guo, Han Lin, Xuan Song, Ye Jin, Yao Liu, Hongrui Guo, Shuhang Liang, Ruipeng Song and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Qingquan BaiDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Haoling LiuDepartment of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Hongyu GuoDepartment of Medical Administration, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Han LinDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Xuan SongDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Ye JinDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yao LiuDepartment of Hepatobiliary Surgery, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Hongrui GuoDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Shuhang LiangDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Ruipeng SongDepartment of Hepatobiliary Surgery, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Jiabei WangDepartment of Hepatobiliary Surgery, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Zhibo QuDepartment of Pediatric Surgery, The Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Huaxin GuoDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Hongchi JiangDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Lianxin LiuDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Haiyan YangDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
First Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CNUniversity of Science and Technology of China · CNAffiliated Hospital of Jiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A further understanding of the molecular mechanism of hepatocellular carcinoma (HCC) is necessary to predict a patient's prognosis and develop new targeted gene drugs. This study aims to identify essential genes related to HCC. We used the Weighted Gene Co-expression Network Analysis (WGCNA) and differential gene expression analysis to analyze the gene expression profile of GSE45114 in the Gene Expression Omnibus (GEO) database and The Cancer Genome Atlas database (TCGA). A total of 37 overlapping genes were extracted from four groups of results. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) enrichment analyses were performed on the 37 overlapping genes. Then, we used the STRING database to map the protein interaction (PPI) network of 37 overlapping genes. Ten hub genes were screened according to the Maximal Clique Centrality (MCC) score using the Cytohubba plugin of Cytoscape (including FOS, EGR1, EPHA2, DUSP1, IGFBP3, SOCS2, ID1, DUSP6, MT1G, and MT1H). Most hub genes show a significant association with immune infiltration types and tumor stemness of microenvironment in HCC. According to Univariate Cox regression analysis and Kaplan-Meier survival estimation, SOCS2 was positively correlated with overall survival (OS), and IGFBP3 was negatively correlated with OS. Moreover, the expression of IGFBP3 increased with the increase of the clinical stage, while the expression of SOCS2 decreased with the increase of the clinical stage. In conclusion, our findings suggest that SOCS2 and IGFBP3 may play an essential role in the development of HCC and may serve as a potential biomarker for future diagnosis and treatment.

Indexed as

differential gene expression analysishepatocellular carcinomaoverall survivaltumor microenvironmentweighted gene co-expression network analysis

Identifiers

PMID33414813
PMCPMC7783465
OpenAlexW3116247875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.